TY - JOUR KW - Clofazimine KW - Dapsone KW - Drug Resistance KW - Drug Therapy, Combination KW - Humans KW - Leprostatic Agents KW - leprosy KW - Rifampin AU - Bahmer F A AU - Menzel S AB -

The rise in the incidence of dapsone-resistant leprosy requires new therapeutic approaches. Based on the recommendations of the WHO and the experiences from many countries where leprosy is endemic, a standardized treatment regimen is presented. It is based on the combination of three chemotherapeutically active substances.

BT - Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete C1 - http://www.ncbi.nlm.nih.gov/pubmed/3557977?dopt=Abstract DA - 1987 Jan IS - 1 J2 - Hautarzt LA - ger N2 -

The rise in the incidence of dapsone-resistant leprosy requires new therapeutic approaches. Based on the recommendations of the WHO and the experiences from many countries where leprosy is endemic, a standardized treatment regimen is presented. It is based on the combination of three chemotherapeutically active substances.

PY - 1987 SP - 1 EP - 3 T2 - Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete TI - [Therapy of leprosy today]. VL - 38 SN - 0017-8470 ER -